Local activity of matrix metalloproteinases in a case of botryoid sarcoma

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 67, Issue 2, 1996, Pages 169-172

  Rechberger, Tomasz ^a   Postawski, Krzysztof ^a   Skorupski, Pawel ^a   Kotarski, Jan ^a   Jakowicki, Jerzy A ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Botryoid sarcoma; Interstitial collagenase; Type IV collagenases

Indexed keywords

COLLAGEN TYPE 4; COLLAGENASE; GELATINASE;

ADULT; ARTICLE; CANCER INVASION; EMBRYONAL RHABDOMYOSARCOMA; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL;

EID: 0030218053     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(96)02463-3     Document Type: Article

References (27)

1. [1] Marcel MW, van Roy FM, Bracke ME. How and when do tumor cells metastasize. Crit Rev Oncogen 1993; 4: 559-594.
2. [2] Stettler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990; 9: 289-303.
3. [3] Woessner JE Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-2154.
4. [4] Matrisian LM. The matrix-degrading metalloproteinases. BioEssays 1992; 14: 455-463.
5. [5] van der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991; 5: 2814-2823.
6. [6] Parffit AM. Bone remodelling and bone loss; understanding the pathophysiology of osteoporosis. Clin Obstet Gynecol 1987; 30: 789-811.
7. [7] Rechberger T, Woessner JF Jr. Collagenase, its inhibitors, and decorin in the lower uterine segment in pregnant women. Am J Obstet Gynecol 1993; 168: 1598-1603.
8. [8] Cawston TE. Protein inhibitors of metalloproteinases. In: Barret AJ, Salvesen G. eds. Proteinase inhibitors. Amsterdam: Elsevier, 1986; 589-610.
9. [9] Apte SS, Olsen BR, Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMP-3) and its inhibitory activities define the distinct TIMP Gene Family. J Biol Chem 1995; 270: 14313-14318.
10. [10] Moneagudo C, Merino M, San-Juan J et al. Immunohistologic distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 1990; 136: 585-592.
11. [11] Garbisa S, D'Errico A, Grigioni W et al. Type IV collagenase augmentation associated with colorectal and gastric cancer progression. In: Genetic mechanism in carcinogenesis and tumor progression. New York: Wiley-Liss, Inc, 1990; 203-212.
12. [12] Bonfil DR, Reddel RR, Ura H et al. Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line. J Natl Cancer Instit 1989; 81: 587-594.
13. [13] Rechberger T, Postawski K, Skorupski P et al. Tissue MMP-9 activity-biochemical marker of uterine adenocarcinoma malignancy? Book of Abstracts XXIIIrd Meeting of the International Society for Oncodevelopmental Biology and Medicine. Montreal 1995; 67.
14. 3 H] acetylated collagen. Anal Biochem 1985; 148: 174-181.
15. [15] Lowry OH, Rosenbrough HJ, Farr AL et al. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 93: 265-275.
16. [16] Hibbs M, Hasty KA, Seyer JM et al. Biochemical and immunological characterisation of the secreted forms of human neutrophil gelatinase. J Biol Chem 1985; 260: 2493-2500.
17. [17] Fisher SJ, Cui TY, Zhang L et al. Adhesive and degradative properties of human placental cytotrophobalst cells in vitro. J Cell Biol 1989; 109: 891-902.
18. [18] Mainardi CL, Hibbs MS, Hasty KA et al. Purification of a type IV collagen degrading metalloproteinase from rabbit alveolar macrophages. Coll Rel Res 1984; 4: 479-492.
19. [19] Bernhard EJ, Muschel RJ, Hughes EN. Mr 92 000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 1990; 50: 3872-3877.
20. [20] Yamagata S, Ito Y, Tanaka R et al. Geletinases of metastatic cell lines of murine colonic carcinoma as detected by substrategel electrophoresis. Biochem Biophys Res Comm 1988; 151: 158-162.
21. [21] Kossakowska AE, Urbański SJ, Huchcroft SA et al. Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metaloproteinases-1 (TIMP-1) RNAs. Oncol Res 1992; 4: 233-240.
22. [22] Tamakoshi K, Kikkawa F, Nawa A et al. Different pattern of zymography between human gynecologic normal and malignant tissues. Am J Obstet Gynecol 1994; 171: 478-84.
23. [23] Autio-Harmainen H, Apaja-Sarkkinen M, Martikainen J et al. Production of basement membrane laminin and type IV collagen by tumors of striated muscle: an immunohistochemical study of rhabdomyosarcomas of different histologic types and a benign vaginal rhabdomyoma. Hum Pathol 1986; 17: 1218-24
24. [24] Nakagawa T, Kubota T, Kabuto M et al. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 1994; 81: 69-77.
25. [25] Slade N, Pavelić J, Bozo K. Type IV collagenase in squamous cell and basal cell skin carcinomas. Arch Dermatol Res 1995; 287: 512-514.
26. [26] Khokha R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Cancer Inst 1994; 86: 299-304.
27. [27] Stetler-Stevenson WG, Brown P, Onisto M et al. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265: 13933-13938.